Neumarkt, Germany
Neumarkt, Germany

Time filter

Source Type

Patent
Bionorica Se | Date: 2012-08-20

The invention relates to a method for producing dry extracts of plants and to pharmaceutical preparations containing the same, more particularly phytopharmaceuticals, which contain at least one ethanolic/aqueous extract of a plant (drug), the plants being selected from the group consisting of: Rumicis herba; Verbena officinalis; Sambucus nigra; Primula veris; and Gentiana lutea and mixtures thereof. The invention further relates to a pharmaceutical for treating inflammatory and/or infectious diseases of the nose and throat area and/or the nasal sinuses, as well as the use thereof.


Patent
Bionorica Se | Date: 2012-12-19

The subject matter of the invention is a pharmaceutical comprising an extract produced by extraction of the leaves of Rhus copallina with a mixture of alcohol and water.


The invention relates to a hydrolyzate from at least one extract of at least one plant material selected from the group consisting of at least one genus: Equiseti, Juglandis, Millefolii, Quercus, Taraxaci, Althaeae, Matricariae, Centaurium, Levisticum, Rosmarinus, Angelica(e), Artemisia, Astragalus, Leonurus, Salvia, Saposhnikovia, Scutellaria, Siegesbeckia, Armoracia, Capsicum, Cistus, Echinacea, Galphimia, Hedera, Melia, Olea, Pelargonium, Phytolacca, Primula, Salix, Thymus, Vitex, and Vitis; and to a mixture thereof and to a method of production and the use thereof. The invention further relates to an agent and drug obtainable on the basis of the hydrolyzate.


The invention relates to a cosmetic or dermatological composition or a means for body care and beauty care, preferably on a pure plant basis, for topical use, containing at least one plant hydrolyzate, in particular selected from the group Althaeae radix (marshmallow root), Angelica(e) dahurica (dahurian angelica), Angelica(e) sinensis (Chinese angelica), Armoracia rusticana (horseradish), Artemisia scoparia (redstem wormwood), Astragalus membranaceus (var. mongolicus) (Chinese milk vetch), Capsicum sp., Capsicum annuum (pepper), Centaurium erythraea (common centaury), Cistus incanus (hairy rockrose), Echinacea angustifolia (narrow-leaved purple coneflower), Echinacea purpurea (eastern purple coneflower), Equiseti herba (horsetail), Galphimia glauca, Gentiana lutea L. (great yellow gentian), Guaiacum officinalis, Hederae folium, Hedera helicis (ivy), Juglandis folium (walnut leaf), Leonurus japonicus (Chinese motherwort), Levesticum radix, Levisticum officinalis (lovage), Matricariae flos (or Flos chamomillae (chamomile flower)), Melia toosendan (chinaberry fruit), Millefolii herba (yarrow), Olea europaea (olive), Pelargonium sp. (geranium), Phytolacca americana (American pokeweed), Primulae flos, Primulae radix, Primula yeris L. (cowslip), Quercus cortex (oak bark), Rosmarinus officinalis (rosemary), Rumicis herba (sorrel herb), Salix sp. (willow), Salvia miltiorrhiza (red sage), Sambucus nigra L. (black elder), Saposhnikovia divaricata (siler), Scutellaria baicalensis (Baikal skullcap), Siegesbeckia pubescens (Siegesbeckia), Taraxaci herba (dandelion root herb), Thymus L. (thyme), Verbena officinalis L. (vervain), Vitex agnus castus (monks pepper), Vitis vinifera (common grape vine).


Patent
Bionorica Se | Date: 2016-09-16

The invention relates to a method for producing dry extracts of plants and to pharmaceutical preparations containing the same, more particularly phytopharmaceuticals, which contain at least one ethanolic/aqueous extract of a plant (drug), the plants being selected from the group consisting of: Rumicis herba; Verbena officinalis; Sambucus nigra; Primula veris; and Gentiana lutea and mixtures thereof. The invention further relates to a pharmaceutical for treating inflammatory and/or infectious diseases of the nose and throat area and/or the nasal sinuses, as well as the use thereof.


The invention relates to an extract from thyme (Thymus L.) in combination with primrose (Primula veris) or ivy (Hedera helix) for use as PDE-4 inhibitor in the prophylaxis and treatment of selected diseases and to a corresponding pharmaceutical and use thereof.


The invention relates to an extract made of thyme (Thymus L.) in combination with primrose (Primula veris) or ivy (Hedera helix) for the prophylaxis and treatment of chronic obstructive pulmonary diseases (COPD) and to a corresponding medicinal product and the use thereof.


The invention relates to a detergent, cleaning agent or disinfectant containing at least one plant hydrolyzate, in particular selected from the group including Althaeae radix (marshmallow root), Angelica(e) dahurica (dahurian angelica), Angelica(e) sinensis (Chinese angelica), Armoracia rusticana (horseradish), Artemisia scoparia (redstem wormwood), Astragalus membranaceus (var. mongolicus) (Chinese milk vetch), Capsicum sp., Capsicum annuum (pepper), Centaurium erythraea (common centaury), Cistus incanus (hairy rockrose), Echinacea angustifolia (narrow-leaved purple coneflower), Echinacea purpurea (eastern purple coneflower), Equiseti herba (horsetail), Galphimia glauca, Gentiana lutea L. (great yellow gentian), Guaiacum officinalis, Hederae folium, Hedera helicis (ivy), Juglandis folium (walnut leaf), Leonurus japonicus (Chinese motherwort), Levesticum radix, Levisticum officinalis (lovage), Matricariae flos (or Flos chamomillae (chamomile flower)), Melia toosendan (chinaberry fruit), Millefolii herba (yarrow), Olea europaea (olive), Pelargonium sp. (geranium), Phytolacca americana (American pokeweed), Primulae flos, Primulae radix, Primula veris L. (cowslip), Quercus cortex (oak bark), Rosmarinus officinalis (rosemary) Rumicis herba (sorrel herb), Salix sp. (willow), Salvia miltiorrhiza (red sage), Sambucus nigra L. (black elder), Saposhnikovia divaricata (slier), Scutellaria baicalensis (Baikal skullcap), Siegesbeckia pubescens (Siegesbeckia), Taraxaci herba (dandelion root herb), Thymus L. (thyme), Verbena officinalis L. (vervain), Vitex agnus cactus (monks pepper), and Vitis vinifera (common grape vine).


This report studies Drugs for Sinusitis in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa, focuses on the top Manufacturers in each country, covering Sanofi Bayer AG Pfizer AstraZeneca?Plc Novartis?AG. Johnson & Johnson Merck Amgen Bionorica SE Dr. Reddy's Laboratories Huasun Market Segment by Countries, this report splits Global into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 (forecast), like 1 United States 2 Canada 3 Mexico 4 Germany 5 France 6 UK 7 Italy 8 Russia 9 China 10 Japan 11 India 12 Korea 13 Southeast Asia 14 Australia 15 Brazil 16 Middle East 17 Africa Split by Product Types, with sales, revenue, price, market share of each type, can be divided into Antibiotics Corticosteroids Decongestants Other Split by applications, this report focuses on sales, market share and growth rate of Drugs for Sinusitis in each application, can be divided into Acute Sinusitis Chronic Sinusitis 1 Drugs for Sinusitis Market Overview 1.1 Product Overview and Scope of Drugs for Sinusitis 1.2 Drugs for Sinusitis Segment by Types 1.2.1 Global Sales Market Share of Drugs for Sinusitis by Types in 2015 1.2.2 Antibiotics 1.2.3 Corticosteroids 1.2.4 Decongestants 1.2.5 Other 1.3 Drugs for Sinusitis Segment by Applications 1.3.1 Drugs for Sinusitis Consumption Market Share by Applications in 2015 1.3.2 Acute Sinusitis 1.3.3 Chronic Sinusitis 1.4 Drugs for Sinusitis Market by Countries 1.4.1 United States Status and Prospect (2012-2022) 1.4.2 Canada Status and Prospect (2012-2022) 1.4.3 Germany Status and Prospect (2012-2022) 1.4.4 France Status and Prospect (2012-2022) 1.4.5 UK Status and Prospect (2012-2022) 1.4.6 Italy Status and Prospect (2012-2022) 1.4.7 Russia Status and Prospect (2012-2022) 1.4.8 China Status and Prospect (2012-2022) 1.4.9 Japan Status and Prospect (2012-2022) 1.4.10 India Status and Prospect (2012-2022) 1.4.11 Korea Status and Prospect (2012-2022) 1.4.12 Southeast Asia Status and Prospect (2012-2022) 1.4.13 Australia Status and Prospect (2012-2022) 1.4.14 Brazil Status and Prospect (2012-2022) 1.4.15 Mexico Status and Prospect (2012-2022) 1.4.16 Middle East Status and Prospect (2012-2022) 1.4.17 Africa Status and Prospect (2012-2022) 1.5 Global Drugs for Sinusitis Overview and Market Size (Value) (2012-2022) 1.5.1 Global Market Drugs for Sinusitis Overview 1.5.2 Global Market Drugs for Sinusitis Revenue (Million USD) and Growth Rate (2012-2022) 2 Global Drugs for Sinusitis Sales, Revenue (Value) and Market Share by Manufacturers 2.1 Global Drugs for Sinusitis Sales and Market Share in 2015 and 2016 by Manufacturers 2.2 Global Drugs for Sinusitis Revenue and Market Share by Manufacturers in 2015 and 2016 2.3 Global Drugs for Sinusitis Average Price by Manufacturers in 2015 and 2016 2.4 Global Drugs for Sinusitis Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers 2.5 Drugs for Sinusitis Market Competitive Situation and Trends 2.5.1 Drugs for Sinusitis Market Concentration Rate 2.5.2 Drugs for Sinusitis Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Drugs for Sinusitis Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 3.1 Global Drugs for Sinusitis Sales, Revenue and Market Share by Countries (2012-2017) 3.1.1 Global Drugs for Sinusitis Sales and Market Share by Countries (2012-2017) 3.1.2 Global Drugs for Sinusitis Revenue and Market Share by Countries (2012-2017) 3.1.3 Global Drugs for Sinusitis Price by Countries (2012-2017) 3.2 Global Drugs for Sinusitis Sales, Revenue, Market Share and Price by Type (2012-2017) 3.2.1 Global Drugs for Sinusitis Sales and Market Share by Type (2012-2017) 3.2.2 Global Drugs for Sinusitis Revenue and Market Share by Type (2012-2017) 3.2.3 Global Drugs for Sinusitis Price by Type (2012-2017) 3.3 Global Drugs for Sinusitis Sales and Market Share by Application (2012-2017) 3.4 Global Market Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 4 Global Drugs for Sinusitis Manufacturers Profiles/Analysis 4.1 Sanofi 4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.1.2 Drugs for Sinusitis Product Types, Application and Specification 4.1.2.1 Type 1 4.1.2.2 Type 2 4.1.3 Sanofi Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 4.1.4 Main Business/Business Overview 4.2 Bayer AG 4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.2.2 Drugs for Sinusitis Product Types, Application and Specification 4.2.2.1 Type 1 4.2.2.2 Type 2 4.2.3 Bayer AG Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 4.2.4 Main Business/Business Overview 4.3 Pfizer 4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.3.2 Drugs for Sinusitis Product Types, Application and Specification 4.3.2.1 Type 1 4.3.2.2 Type 2 4.3.3 Pfizer Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 4.3.4 Main Business/Business Overview 4.4 AstraZeneca?Plc 4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.4.2 Drugs for Sinusitis Product Types, Application and Specification 4.4.2.1 Type 1 4.4.2.2 Type 2 4.4.3 AstraZeneca?Plc Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 4.4.4 Main Business/Business Overview 4.5 Novartis?AG. 4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.5.2 Drugs for Sinusitis Product Types, Application and Specification 4.5.2.1 Type 1 4.5.2.2 Type 2 4.5.3 Novartis?AG. Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 4.5.4 Main Business/Business Overview 4.6 Johnson & Johnson 4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.6.2 Drugs for Sinusitis Product Types, Application and Specification 4.6.2.1 Type 1 4.6.2.2 Type 2 4.6.3 Johnson & Johnson Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 4.6.4 Main Business/Business Overview 4.7 Merck 4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.7.2 Drugs for Sinusitis Product Types, Application and Specification 4.7.2.1 Type 1 4.7.2.2 Type 2 4.7.3 Merck Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 4.7.4 Main Business/Business Overview 4.8 Amgen 4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.8.2 Drugs for Sinusitis Product Types, Application and Specification 4.8.2.1 Type 1 4.8.2.2 Type 2 4.8.3 Amgen Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 4.8.4 Main Business/Business Overview 4.9 Bionorica SE 4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.9.2 Drugs for Sinusitis Product Types, Application and Specification 4.9.2.1 Type 1 4.9.2.2 Type 2 4.9.3 Bionorica SE Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 4.9.4 Main Business/Business Overview 4.10 Dr. Reddy's Laboratories 4.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.10.2 Drugs for Sinusitis Product Types, Application and Specification 4.10.2.1 Type 1 4.10.2.2 Type 2 4.10.3 Dr. Reddy's Laboratories Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 4.10.4 Main Business/Business Overview 4.11 Huasun 4.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 4.11.2 Drugs for Sinusitis Product Types, Application and Specification 4.11.2.1 Type 1 4.11.2.2 Type 2 4.11.3 Huasun Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 4.11.4 Main Business/Business Overview 5 North America Drugs for Sinusitis Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 5.1 North America Drugs for Sinusitis Sales, Revenue and Market Share by Countries (2012-2017) 5.1.1 North America Drugs for Sinusitis Sales and Market Share by Countries (2012-2017) 5.1.2 North America Drugs for Sinusitis Revenue and Market Share by Countries (2012-2017) 5.1.3 North America Drugs for Sinusitis Price by Countries (2012-2017) 5.1.4 North America Market Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 5.1.5 North America Drugs for Sinusitis Import & Export (2012-2017) 5.2 United States Drugs for Sinusitis Sales, Revenue and Growth, by Type and Application (2012-2017) 5.2.1 United States Drugs for Sinusitis Sales, Revenue and Growth Rate (2012-2017) 5.2.2 United States Drugs for Sinusitis Sales and Market Share by Type (2012-2017) 5.2.3 United States Drugs for Sinusitis Revenue and Market Share by Type (2012-2017) 5.2.4 United States Drugs for Sinusitis Price by Type (2012-2017) 5.2.5 United States Drugs for Sinusitis Sales and Market Share by Application (2012-2017) 5.3 Canada Drugs for Sinusitis Sales, Revenue and Growth, by Type and Application (2012-2017) 5.3.1 Canada Drugs for Sinusitis Sales, Revenue and Growth Rate (2012-2017) 5.3.2 Canada Drugs for Sinusitis Sales and Market Share by Type (2012-2017) 5.3.3 Canada Drugs for Sinusitis Revenue and Market Share by Type (2012-2017) 5.3.4 Canada Drugs for Sinusitis Price by Type (2012-2017) 5.3.5 Canada Drugs for Sinusitis Sales and Market Share by Application (2012-2017) 6 Latin America Drugs for Sinusitis Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 6.1 Latin America Drugs for Sinusitis Sales, Revenue and Market Share by Countries (2012-2017) 6.1.1 Latin America Drugs for Sinusitis Sales and Market Share by Countries (2012-2017) 6.1.2 Latin America Drugs for Sinusitis Revenue and Market Share by Countries (2012-2017) 6.1.3 Latin America Drugs for Sinusitis Price by Countries (2012-2017) 6.1.4 Latin America Market Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 6.1.5 Latin America Drugs for Sinusitis Import & Export (2012-2017) 6.2 Mexico Drugs for Sinusitis Sales, Revenue and Growth, by Type and Application (2012-2017) 6.2.1 Mexico Drugs for Sinusitis Sales, Revenue and Growth Rate (2012-2017) 6.2.2 Mexico Drugs for Sinusitis Sales and Market Share by Type (2012-2017) 6.2.3 Mexico Drugs for Sinusitis Revenue and Market Share by Type (2012-2017) 6.2.4 Mexico Drugs for Sinusitis Price by Type (2012-2017) 6.2.5 Mexico Drugs for Sinusitis Sales and Market Share by Application (2012-2017) 6.3 Brazil Drugs for Sinusitis Sales, Revenue and Growth, by Type and Application (2012-2017) 6.3.1 Brazil Drugs for Sinusitis Sales, Revenue and Growth Rate (2012-2017) 6.3.2 Brazil Drugs for Sinusitis Sales and Market Share by Type (2012-2017) 6.3.3 Brazil Drugs for Sinusitis Revenue and Market Share by Type (2012-2017) 6.3.4 Brazil Drugs for Sinusitis Price by Type (2012-2017) 6.3.5 Brazil Drugs for Sinusitis Sales and Market Share by Application (2012-2017) Get It Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=789131


This report studies Drugs for Sinusitis in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top Drugs for Sinusitis Players in each region, with sales, price, revenue and market share for top manufacturer, covering Sanofi Bayer AG Pfizer AstraZeneca?Plc Novartis?AG. Johnson & Johnson Merck Amgen Bionorica SE Dr. Reddy's Laboratories Huasun Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top 5 players in these regions, from 2012 to 2017 (forecast), like North America (United States, Canada and Mexico) Asia-Pacific (China, Japan, Southeast Asia, India and Korea) Europe (Germany, UK, France, Italy and Russia etc. South America (Brazil, Chile, Peru and Argentina) Middle East and Africa (Egypt, South Africa, Saudi Arabia) Split by Product Types, with sales, revenue, price, market share of each type, can be divided into Antibiotics Corticosteroids Decongestants Other Split by applications, this report focuses on sales, market share and growth rate of Drugs for Sinusitis in each application, can be divided into Acute Sinusitis Chronic Sinusitis 1 Drugs for Sinusitis Market Overview 1.1 Product Overview and Scope of Drugs for Sinusitis 1.2 Drugs for Sinusitis Segment by Types 1.2.1 Global Sales Market Share of Drugs for Sinusitis by Types in 2015 1.2.2 Antibiotics 1.2.3 Corticosteroids 1.2.4 Decongestants 1.2.5 Other 1.3 Drugs for Sinusitis Segment by Applications 1.3.1 Drugs for Sinusitis Consumption Market Share by Applications in 2015 1.3.2 Acute Sinusitis 1.3.3 Chronic Sinusitis 1.4 Drugs for Sinusitis Market by Regions 1.4.1 North America Status and Prospect (2012-2022) 1.4.2 Asia-Pacific Status and Prospect (2012-2022) 1.4.3 Europe Status and Prospect (2012-2022) 1.4.4 South America Status and Prospect (2012-2022) 1.4.5 Middle East and Africa Status and Prospect (2012-2022) 1.5 Global Market Size (Value) of Drugs for Sinusitis (2012-2022) 2 Global Drugs for Sinusitis Sales, Revenue (value) and Market Share by Players 2.1 Global Drugs for Sinusitis Sales and Market Share in 2015 and 2016 by Players 2.2 Global Drugs for Sinusitis Revenue and Market Share by Players in 2015 and 2016 2.3 Global Drugs for Sinusitis Average Price by Players in 2015 and 2016 2.4 Global Drugs for Sinusitis Manufacturing Base Distribution, Sales Area, Product Types by Players 2.5 Drugs for Sinusitis Market Competitive Situation and Trends 2.5.1 Drugs for Sinusitis Market Concentration Rate 2.5.2 Drugs for Sinusitis Market Share of Top 3 and Top 5 Players 2.5.3 Mergers & Acquisitions, Expansion 3 Global Drugs for Sinusitis Sales, Revenue (Value) by Regions, Type and Application (2012-2017) 3.1 Global Drugs for Sinusitis Sales, Revenue and Market Share by Regions (2012-2017) 3.1.1 Global Drugs for Sinusitis Sales and Market Share by Regions (2012-2017) 3.1.2 Global Drugs for Sinusitis Revenue and Market Share by Regions (2012-2017) 3.2 Global Drugs for Sinusitis Sales, Revenue, Market Share and Price by Type (2012-2017) 3.2.1 Global Drugs for Sinusitis Sales and Market Share by Type (2012-2017) 3.2.2 Global Drugs for Sinusitis Revenue and Market Share by Type (2012-2017) 3.2.3 Global Drugs for Sinusitis Price by Type (2012-2017) 3.3 Global Drugs for Sinusitis Sales and Market Share by Application (2012-2017) 3.4 Global Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 4 North America Top 5 Players Drugs for Sinusitis Sales, Revenue and Price 4.1 North America Top 5 Players Drugs for Sinusitis Sales, Revenue and Market Share in 2015 and 2016 4.1.1 North America Top 5 Players Drugs for Sinusitis Sales and Market Share in 2015 and 2016 4.1.2 North America Top 5 Players Drugs for Sinusitis Revenue and Market Share in 2015 and 2016 4.2 North America Drugs for Sinusitis Sales, Revenue, Market Share and Price by Type (2012-2017) 4.2.1 North America Drugs for Sinusitis Sales and Market Share by Type (2012-2017) 4.2.2 North America Drugs for Sinusitis Revenue and Market Share by Type (2012-2017) 4.2.3 North America Drugs for Sinusitis Price by Type (2012-2017) 4.3 North America Drugs for Sinusitis Sales and Market Share by Application (2012-2017) 4.4 North America Drugs for Sinusitis Sales and Market Share by Country (US, Canada and Mexico) (2012-2017) 4.5 North America Drugs for Sinusitis Import & Export (2012-2017) 5 Europe Top 5 Players Drugs for Sinusitis Sales, Revenue and Price 5.1 Europe Top 5 Players Drugs for Sinusitis Sales, Revenue and Market Share in 2015 and 2016 5.1.1 Europe Top 5 Players Drugs for Sinusitis Sales and Market Share in 2015 and 2016 5.1.2 Europe Top 5 Players Drugs for Sinusitis Revenue and Market Share in 2015 and 2016 5.2 Europe Drugs for Sinusitis Sales, Revenue, Market Share and Price by Type (2012-2017) 5.2.1 Europe Drugs for Sinusitis Sales and Market Share by Type (2012-2017) 5.2.2 Europe Drugs for Sinusitis Revenue and Market Share by Type (2012-2017) 5.2.3 Europe Drugs for Sinusitis Price by Type (2012-2017) 5.3 Europe Drugs for Sinusitis Sales and Market Share by Application (2012-2017) 5.4 Europe Drugs for Sinusitis Sales and Market Share by Country (Germany, UK, France, Italy and Russia) (2012-2017) 5.5 Europe Drugs for Sinusitis Import & Export (2012-2017) 6 Asia-Pacific Top 5 Players Drugs for Sinusitis Sales, Revenue and Price 6.1 Asia-Pacific Top 5 Players Drugs for Sinusitis Sales, Revenue and Market Share in 2015 and 2016 6.1.1 Asia-Pacific Top 5 Players Drugs for Sinusitis Sales and Market Share in 2015 and 2016 6.1.2 Asia-Pacific Top 5 Players Drugs for Sinusitis Revenue and Market Share in 2015 and 2016 6.2 Asia-Pacific Drugs for Sinusitis Sales, Revenue, Market Share and Price by Type (2012-2017) 6.2.1 Asia-Pacific Drugs for Sinusitis Sales and Market Share by Type (2012-2017) 6.2.2 Asia-Pacific Drugs for Sinusitis Revenue and Market Share by Type (2012-2017) 6.2.3 Asia-Pacific Drugs for Sinusitis Price by Type (2012-2017) 6.3 Asia-Pacific Drugs for Sinusitis Sales and Market Share by Application (2012-2017) 6.4 Asia-Pacific Drugs for Sinusitis Sales and Market Share by Country (China, Japan, Southeast Asia, India and Korea) (2012-2017) 6.5 Asia-Pacific Drugs for Sinusitis Import & Export (2012-2017) 7 South America Top 5 Players Drugs for Sinusitis Sales, Revenue and Price 7.1 South America Top 5 Players Drugs for Sinusitis Sales, Revenue and Market Share in 2015 and 2016 7.1.1 South America Top 5 Players Drugs for Sinusitis Sales and Market Share in 2015 and 2016 7.1.2 South America Top 5 Players Drugs for Sinusitis Revenue and Market Share in 2015 and 2016 7.2 South America Drugs for Sinusitis Sales, Revenue, Market Share and Price by Type (2012-2017) 7.2.1 South America Drugs for Sinusitis Sales and Market Share by Type (2012-2017) 7.2.2 South America Drugs for Sinusitis Revenue and Market Share by Type (2012-2017) 7.2.3 South America Drugs for Sinusitis Price by Type (2012-2017) 7.3 South America Drugs for Sinusitis Sales and Market Share by Application (2012-2017) 7.4 South America Drugs for Sinusitis Sales and Market Share by Country (Brazil, Argentina, Chile and Peru) (2012-2017) 7.5 South America Drugs for Sinusitis Import & Export (2012-2017) 8 Middle East & Africa Top 5 Players Drugs for Sinusitis Sales, Revenue and Price 8.1 Middle East & Africa Top 5 Players Drugs for Sinusitis Sales, Revenue and Market Share in 2015 and 2016 8.1.1 Middle East & Africa Top 5 Players Drugs for Sinusitis Sales and Market Share in 2015 and 2016 8.1.2 Middle East & Africa Top 5 Players Drugs for Sinusitis Revenue and Market Share in 2015 and 2016 8.2 Middle East & Africa Drugs for Sinusitis Sales, Revenue, Market Share and Price by Type (2012-2017) 8.2.1 Middle East & Africa Drugs for Sinusitis Sales and Market Share by Type (2012-2017) 8.2.2 Middle East & Africa Drugs for Sinusitis Revenue and Market Share by Type (2012-2017) 8.2.3 Middle East & Africa Drugs for Sinusitis Price by Type (2012-2017) 8.3 Middle East & Africa Drugs for Sinusitis Sales and Market Share by Application (2012-2017) 8.4 Middle East & Africa Drugs for Sinusitis Sales and Market Share by Country (Egypt, Saudi Arabia, South Africa and Iran) (2012-2017) 8.5 Middle East & Africa Drugs for Sinusitis Import & Export (2012-2017) 9 Global Drugs for Sinusitis Players Profiles/Analysis 9.1 Sanofi 9.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.1.2 Drugs for Sinusitis Product Types, Application and Specification 9.1.2.1 Type 1 9.1.2.2 Type 2 9.1.3 Sanofi Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 9.1.4 Main Business/Business Overview 9.2 Bayer AG 9.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.2.2 Drugs for Sinusitis Product Types, Application and Specification 9.2.2.1 Type 1 9.2.2.2 Type 2 9.2.3 Bayer AG Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 9.2.4 Main Business/Business Overview 9.3 Pfizer 9.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.3.2 Drugs for Sinusitis Product Types, Application and Specification 9.3.2.1 Type 1 9.3.2.2 Type 2 9.3.3 Pfizer Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 9.3.4 Main Business/Business Overview 9.4 AstraZeneca?Plc 9.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.4.2 Drugs for Sinusitis Product Types, Application and Specification 9.4.2.1 Type 1 9.4.2.2 Type 2 9.4.3 AstraZeneca?Plc Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 9.4.4 Main Business/Business Overview 9.5 Novartis?AG. 9.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.5.2 Drugs for Sinusitis Product Types, Application and Specification 9.5.2.1 Type 1 9.5.2.2 Type 2 9.5.3 Novartis?AG. Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 9.5.4 Main Business/Business Overview 9.6 Johnson & Johnson 9.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.6.2 Drugs for Sinusitis Product Types, Application and Specification 9.6.2.1 Type 1 9.6.2.2 Type 2 9.6.3 Johnson & Johnson Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 9.6.4 Main Business/Business Overview 9.7 Merck 9.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.7.2 Drugs for Sinusitis Product Types, Application and Specification 9.7.2.1 Type 1 9.7.2.2 Type 2 9.7.3 Merck Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 9.7.4 Main Business/Business Overview 9.8 Amgen 9.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.8.2 Drugs for Sinusitis Product Types, Application and Specification 9.8.2.1 Type 1 9.8.2.2 Type 2 9.8.3 Amgen Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 9.8.4 Main Business/Business Overview 9.9 Bionorica SE 9.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.9.2 Drugs for Sinusitis Product Types, Application and Specification 9.9.2.1 Type 1 9.9.2.2 Type 2 9.9.3 Bionorica SE Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 9.9.4 Main Business/Business Overview 9.10 Dr. Reddy's Laboratories 9.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.10.2 Drugs for Sinusitis Product Types, Application and Specification 9.10.2.1 Type 1 9.10.2.2 Type 2 9.10.3 Dr. Reddy's Laboratories Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 9.10.4 Main Business/Business Overview 9.11 Huasun 9.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.11.2 Drugs for Sinusitis Product Types, Application and Specification 9.11.2.1 Type 1 9.11.2.2 Type 2 9.11.3 Huasun Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2012-2017) 9.11.4 Main Business/Business Overview Get It Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=789111

Loading Bionorica SE collaborators
Loading Bionorica SE collaborators